share_log

Scotiabank Downgrades Syndax Pharmaceuticals to Sector Perform, Lowers Price Target to $23

Scotiabank Downgrades Syndax Pharmaceuticals to Sector Perform, Lowers Price Target to $23

豐業銀行將Syndax Pharmicals的評級下調至行業表現,將目標股價下調至23美元
Benzinga ·  01/31 09:58

Scotiabank analyst George Farmer downgrades Syndax Pharmaceuticals (NASDAQ:SNDX) from Sector Outperform to Sector Perform and lowers the price target from $36 to $23.

豐業銀行分析師喬治·法默將Syndax Pharmicals(納斯達克股票代碼:SNDX)的評級從板塊跑贏大盤下調至板塊表現,並將目標股價從36美元下調至23美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論